Immune and hemorheological changes in chronic fatigue syndrome
- PMID: 20064266
- PMCID: PMC2829521
- DOI: 10.1186/1479-5876-8-1
Immune and hemorheological changes in chronic fatigue syndrome
Abstract
Background: Chronic Fatigue Syndrome (CFS) is a multifactorial disorder that affects various physiological systems including immune and neurological systems. The immune system has been substantially examined in CFS with equivocal results, however, little is known about the role of neutrophils and natural killer (NK) phenotypes in the pathomechanism of this disorder. Additionally the role of erythrocyte rheological characteristics in CFS has not been fully expounded. The objective of this present study was to determine deficiencies in lymphocyte function and erythrocyte rheology in CFS patients.
Methods: Flow cytometric measurements were performed for neutrophil function, lymphocyte numbers, NK phenotypes (CD56(dim)CD16(+) and CD56(bright)CD16(-)) and NK cytotoxic activity. Erythrocyte aggregation, deformability and fibrinogen levels were also assessed.
Results: CFS patients (n = 10) had significant decreases in neutrophil respiratory burst, NK cytotoxic activity and CD56(bright)CD16(-) NK phenotypes in comparison to healthy controls (n = 10). However, hemorheological characteristic, aggregation, deformability, fibrinogen, lymphocyte numbers and CD56(dim)CD16(+) NK cells were similar between the two groups.
Conclusion: These results indicate immune dysfunction as potential contributors to the mechanism of CFS, as indicated by decreases in neutrophil respiratory burst, NK cell activity and NK phenotypes. Thus, immune cell function and phenotypes may be important diagnostic markers for CFS. The absence of rheological changes may indicate no abnormalities in erythrocytes of CFS patients.
Figures






Similar articles
-
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.J Transl Med. 2016 Apr 21;14:97. doi: 10.1186/s12967-016-0859-z. J Transl Med. 2016. PMID: 27098723 Free PMC article.
-
Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.Scand J Immunol. 2016 Jan;83(1):44-51. doi: 10.1111/sji.12388. Scand J Immunol. 2016. PMID: 26381393
-
Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).BMC Immunol. 2015 Jun 2;16:35. doi: 10.1186/s12865-015-0101-4. BMC Immunol. 2015. PMID: 26032326 Free PMC article.
-
CD56bright natural killer (NK) cells: an important NK cell subset.Immunology. 2009 Apr;126(4):458-65. doi: 10.1111/j.1365-2567.2008.03027.x. Immunology. 2009. PMID: 19278419 Free PMC article. Review.
-
Role of chemokines in the biology of natural killer cells.Curr Top Microbiol Immunol. 2010;341:37-58. doi: 10.1007/82_2010_20. Curr Top Microbiol Immunol. 2010. PMID: 20369317 Review.
Cited by
-
Evaluation of natural killer cell assay performance on shipped blood specimens.J Immunol Methods. 2021 Aug;495:113049. doi: 10.1016/j.jim.2021.113049. Epub 2021 Apr 2. J Immunol Methods. 2021. PMID: 33819446 Free PMC article.
-
High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.PLoS One. 2014 Sep 19;9(9):e102783. doi: 10.1371/journal.pone.0102783. eCollection 2014. PLoS One. 2014. PMID: 25238588 Free PMC article.
-
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.Syst Rev. 2019 Nov 14;8(1):279. doi: 10.1186/s13643-019-1202-6. Syst Rev. 2019. PMID: 31727160 Free PMC article.
-
Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?Metab Brain Dis. 2019 Apr;34(2):385-415. doi: 10.1007/s11011-019-0388-6. Epub 2019 Feb 13. Metab Brain Dis. 2019. PMID: 30758706 Free PMC article. Review.
-
Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients.Neuropsychiatry (London). 2018;8(4):1249-1262. doi: 10.4172/Neuropsychiatry.1000454. Neuropsychiatry (London). 2018. PMID: 30364895 Free PMC article.
References
-
- Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953–959. - PubMed
-
- Ojo-Amaise EA, Conley EJ, Peters JB. Decreased natural killer cell activity is associated with severity of chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1):157–159. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials